One exception is seen in patients and animal models of Ehlers-Danlos syndrome type IV in which the COL3A1 gene mutation results in reduced collagen III but with concurrent increased myofibroblast expression. This evidence concerns the gene COL3A1 and Ehlers-Danlos syndrome, vascular type.